On this page are position statements of organizations and individuals about the drug shortage. (See below for USA and Europe)
International Society of Pharmaceutical Engineers, Plan to prevent drug shortages, released 14 October 2014. [plan can be downloaded from this site]
Physicians Against Drug Shortages launch new website explaining GPO cause of drug shortage, 11 August 2014.
Canada’s response to Eli Lilly and Company v. Government of Canada, 30 June 2014.
Webmaster Jacalyn Duffin tells Health Canada what is wrong with the current reporting system, 28 June 2014.
Canadian Epilepsy Alliance, “Canadian Epilepsy Alliance Calls for Changes to Address Drug Shortages,” press release 19 June 2014.
Parenteral Drug Association, PDA Annual conference will address drug shortages and global access, 7-9 April 2014. Registration fees around $3000.
Access to Medication: Aristospan® TH, The Arthritis Society of Canada: Position Paper, March 2014.
Gail Dempsey, Canadian Epilepsy Alliance, 2nd letter to Minister Rona Ambrose about Clobazam shortage, 27 February 2014.
HealthPRO, Minister of Health Rona Ambrose recognizes MSSC for efforts to mitigate drug shortage, HealthPRO Progress, October 2013.
Multistakeholder Steering Committee, Multistakeholder Toolkit: A Toolkit for Improved Understanding and Transparency in Drug Shortage Response in Canada, September 2013
Canadian Pharmacists Association to co-host international conference on drug shortages on 20-21 June in Toronto. Invitation only, but a report will be published. For some recommendations, see this page and also IPF website.
Doctors without Borders, Countries must fix critical access to medicines flaws in Trans-Pacific Trade Pact, 14 May 2013
International Society for Pharmaceutical Engineering (IPSE), Drug Shortage Initiative, press release, 14 February 2013. Report can be downloaded here, June 2013. Upcoming events also listed at the website.
Patrick Sullivan, Drug shortage extracting “terrible toll” on patients, Canadian Medical Association, 24 January 2013.
Canadian Pharmacists Association response to plans of the Council of the Federation to by six generic drugs, 18 January 2013.
Best Medicines Coalition, Value, Safety and Secure Supply: Pan Canadian Generic Drug Value Price Initiative, 6 November 2012.
Royal College of Physicians and Surgeons of Canada, ICRE conference examines threats and solutions to Canada’s prescription drug shortage, press release, 18 October 2012.
Canadian Pharmacists Association response to plans of the Council of the Federation to bulk buy generic drugs, 26 July 2012.
Drug Supply in Canada: A Multi-Stakeholder Responsibility, Report of the Standing Committee on Health, June 2012. Government response expected in early October 2012. For Government’s response October 2012 click here.
Consensus Conference on Drug Shortages, 14-15 June 2012, Emory University Center for Ethics, – Watch for statement here.
American Society for Hematology, Action needed .. to strengthen Drug Shortage Legislation, May 2012
Ontario Pharmacists Association, Ontario’s pharmacists provide solutions that would yield greater savings than the government’s proposed cuts to generic medication pricing, OPAToday, 23 April 2012.
J. Duffin (www.canadadrugshortage.com webmaster), invited Submission to HESA, 2 April 2012.
Canadian Epilepsy Alliance, Canadian Drug Supply, Submission to HESA, 2 April 2012
Best Medicines Coalition, Submission to Standing Committee on Health (HESA), 29 March 2012.
Canadian Medical Association, Submission to the Standing Committee on Health (HESA)–Drug Shortages, 29 March 2012.
On 27 March 2012 the House of Commons Standing Committee on Health (HESA) began hearing from various witnesses, professional groups, patient advocacy groups and concerned citizens. Transcripts of the meetings are posted here. The full report is here, also linked on our Policy and Politics page.
Royal College of Physicians and Surgeons of Canada, Canada’s drug shortage; Highlights of main issues, causes and possible outcomes, 22 March 2012.
Jeff Connell and Shannon Macdonald [CGPA and Rx & D] Statement from Canada’s Pharmaceutical Industry Regarding House of Commons Motion on National Drug Strategy, 16 March 2012.
Gail Attara, Statement on Drug Shortages, Best Medicines Coalition, 12 March 2012
Epilepsy Support Centre page on shortages
Health Canada, webpage, first appeared, November 2011
Canadian Cancer Society, Statement on drug shortages, Oct 2011
Canadian Generic Pharmaceutical Association, statement on drug shortages, Oct 2011 and updated from time to time.
United States and Europe
Sheryl Nass and Margie Patlak, Ensuring Patient Access to Affordable Cancer Drugs: Workshop Summary, National Cancer Policy Forum, Institute of Medicine, 2014 [free download at link].
Gov’t Accountability Office, Group Purchasing Organizations: Funding Structure has Potential Implications for Medicare Costs, released 24 November 2014.
Physicians Against Drug Shortages, Petition to President Obama: STOP generic drug shortages by ending the $300 billion hospital group purchasing (GPO) “pay-to-play” kickback scheme, 25 December 2013.
Andrea Taft and Brendan, Shortages of medicinal products due to manufacturing and quality problems, European Medicines Agency, 5 June 2013.
American Hospital Association, AHA comments on FDA drug shortages task force and strategic plan, 14 March 2013.
Federal Register, FDA seeks public comment for task force on drug shortages, 12 February 2013.
European Medicines Agency [EMA], Reflection paper on medicinal product supply, November 2012
North Coast Medical, GPO’s Business Practices Questioned, 6 September 2012.
Peter J. Pitts, Fixing Drug Shortages, Center for Medicine in the Public Interest, 21 June 2012.
International Call to Action to Alleviate Drug Shortages–European Hematology Association, American Society of Hematology, European Cancer Patient Coalition, 16 June 2012
US Government Accountability Office (GAO), Group Purchasing Organizations: Federal Oversights and Self Regulation, 30 March 2012.